Glycan markers as measure of disease state of hepatic diseases
US9796761B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jul 12, 2010 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Jul 12, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/085
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to developing a glycan markers capable of detecting a hepatic disease, and more specifically to developing a glycan marker indicating a hepatic disease-state. Furthermore, the present invention is also directed to developing a glycan marker capable of distinguishing hepatic disease-states with the progress of hepatocarcinoma. The present inventors identified, among the serum glycoproteins, glycopeptides and glycoproteins in which a glycan structure specifically changes due to a hepatic diseases including hepatocarcinoma and provide these as novel glycan markers (glycopeptide and glycoprotein) specific to hepatic disease-states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.